8-K/A
filed March 24, 2026, 7:59 PM ET
ticker ALBT
CIK 0001630212
other material
confidence high
sentiment neutral
materiality 0.65
Avalon GloboCare corrects share count in $2.8M private placement
Avalon GloboCare Corp.
- The amendment corrects the number of shares reported under Item 3.02 in the original March 2 filing.
- Private placement closed Feb 27: issued 490,197 shares, pre-funded warrants for 5,882,353 shares, and Series A-1/A-2 warrants each for 6,372,550 shares at $0.51 exercise.
- Net proceeds expected ~$2.8M after fees, for operating expenses and working capital.
- H.C. Wainwright as placement agent: 7% cash fee and warrants for 318,628 shares at $0.6375 per share.
- On Feb 19,24,26 issued 287,411; 230,739; 750,522 shares upon net exercise of existing warrants with no proceeds.
Key facts
Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.97
Avalon GloboCare Corp. issued Placement Agent Warrants to purchase up to 318,628 shares of Common Stock of warrant to H.C. Wainwright & Co., LLC (Placement Agent) for cash fee of 7.0% of aggregate gross proceeds plus management fee.
- Security
- warrant
- Shares
- Placement Agent Warrants to purchase up to 318,628 shares of Common Stock
- Purchaser
- H.C. Wainwright & Co., LLC (Placement Agent)
- Consideration
- cash fee of 7.0% of aggregate gross proceeds plus management fee
Exact text from the filing
H.C. Wainwright & Co., LLC as the exclusive placement agent in connection with the Private Placement (the “ Placement Agent ”), the Company paid the Placement Agent a cash fee of 7.0% of the aggregate gross proceeds raised in the Private Placement, plus a management fee equal to 1.0% of the gross proceeds raised in the Private Placement and reimbursement of
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.97
Avalon GloboCare Corp. issued Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock of warrant to institutional investors for Each Warrant has an exercise price of $0.51 per share.
- Security
- warrant
- Shares
- Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock
- Purchaser
- institutional investors
- Consideration
- Each Warrant has an exercise price of $0.51 per share
Exact text from the filing
On February 26, 2026, Avalon GloboCare Corp. (the " Company ") entered into securities purchase agreements (the " Purchase Agreements ") with certain institutional investors ("the " Purchasers ") for the issuance and sale in a private placement (the " Private Placement ") of (i) 490,197 shares (the "Shares") of the Company's common stock, par value $0.0001 per shares (" Common Stock ") at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the "Pre-Funded Warrants") at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common Stock (the " Pre-Funded Warrant Shares "); (iii) Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock (the " Series A-1 Warrants ," and the shares issuable upon exercise thereof, the " Series A-1 Warrant Shares ") and (iv) Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock (the " Series A-2 Warrants ," together with the Series A-1 Warrants, the " Warrants ") and t
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Avalon GloboCare Corp. issued 287,411 shares (Feb 19), 230,739 shares (Feb 24), 750,522 shares (Feb 26) of common stock to warrant holders for net-exercise basis, no proceeds received.
- Security
- common stock
- Shares
- 287,411 shares (Feb 19), 230,739 shares (Feb 24), 750,522 shares (Feb 26)
- Purchaser
- warrant holders
- Consideration
- net-exercise basis, no proceeds received
Exact text from the filing
On each of February 19, 2026, February 24, 2026 and February 26, 2026, the Company issued 287,411, 230,739 and 750,522 shares of its common stock, respectively upon exercise of existing warrants on a net-exercise basis. The February 24, 2026 issuance of warrant exercise shares triggered the disclosure requirement under this Item 3.02. No proceeds were received upon exercise.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.98
Avalon GloboCare Corp. issued pre-funded warrants to purchase up to 5,882,353 shares of Common Stock of warrant to institutional investors for $0.5099 per Pre-Funded Warrant.
- Security
- warrant
- Shares
- pre-funded warrants to purchase up to 5,882,353 shares of Common Stock
- Purchaser
- institutional investors
- Consideration
- $0.5099 per Pre-Funded Warrant
Exact text from the filing
On February 26, 2026, Avalon GloboCare Corp. (the " Company ") entered into securities purchase agreements (the " Purchase Agreements ") with certain institutional investors ("the " Purchasers ") for the issuance and sale in a private placement (the " Private Placement ") of (i) 490,197 shares (the "Shares") of the Company's common stock, par value $0.0001 per shares (" Common Stock ") at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the "Pre-Funded Warrants") at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common Stock (the " Pre-Funded Warrant Shares "); (iii) Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock (the " Series A-1 Warrants ," and the shares issuable upon exercise thereof, the " Series A-1 Warrant Shares ") and (iv) Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock (the " Series A-2 Warrants ," together with the Series A-1 Warrants, the " Warrants ") and t
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.97
Avalon GloboCare Corp. issued Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock of warrant to institutional investors for Each Warrant has an exercise price of $0.51 per share.
- Security
- warrant
- Shares
- Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock
- Purchaser
- institutional investors
- Consideration
- Each Warrant has an exercise price of $0.51 per share
Exact text from the filing
On February 26, 2026, Avalon GloboCare Corp. (the " Company ") entered into securities purchase agreements (the " Purchase Agreements ") with certain institutional investors ("the " Purchasers ") for the issuance and sale in a private placement (the " Private Placement ") of (i) 490,197 shares (the "Shares") of the Company's common stock, par value $0.0001 per shares (" Common Stock ") at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the "Pre-Funded Warrants") at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common Stock (the " Pre-Funded Warrant Shares "); (iii) Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock (the " Series A-1 Warrants ," and the shares issuable upon exercise thereof, the " Series A-1 Warrant Shares ") and (iv) Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock (the " Series A-2 Warrants ," together with the Series A-1 Warrants, the " Warrants ") and t
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.99
Avalon GloboCare Corp. issued 490,197 shares of common stock to institutional investors for $0.51 per Share.
- Security
- common stock
- Shares
- 490,197 shares
- Purchaser
- institutional investors
- Consideration
- $0.51 per Share
Exact text from the filing
On February 26, 2026, Avalon GloboCare Corp. (the " Company ") entered into securities purchase agreements (the " Purchase Agreements ") with certain institutional investors ("the " Purchasers ") for the issuance and sale in a private placement (the " Private Placement ") of (i) 490,197 shares (the "Shares") of the Company's common stock, par value $0.0001 per shares (" Common Stock ") at a purchase price of $0.51 per Share; (ii) pre-funded warrants (the "Pre-Funded Warrants") at a purchase price of 0.5099 per Pre-Funded Warrant to purchase up to an aggregate of 5,882,353 shares of Common Stock (the " Pre-Funded Warrant Shares "); (iii) Series A-1 warrants to purchase up to 6,372,550 shares of Common Stock (the " Series A-1 Warrants ," and the shares issuable upon exercise thereof, the " Series A-1 Warrant Shares ") and (iv) Series A-2 warrants to purchase up to 6,372,550 shares of Common Stock (the " Series A-2 Warrants ," together with the Series A-1 Warrants, the " Warrants ") and t
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Avalon GloboCare Corp. entered into Registration Rights Agreement with certain institutional investors (effective 2026-02-26).
- Action
- entry
- Counterparty
- certain institutional investors
- Effective
- 2026-02-26
Exact text from the filing
the Company entered into a registration rights agreement (the " Registration Rights Agreement "), dated as of February 26, 2026, with the Purchaser
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Avalon GloboCare Corp. entered into Purchase Agreements with certain institutional investors (effective 2026-02-26).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain institutional investors
- Effective
- 2026-02-26
Exact text from the filing
On February 26, 2026, Avalon GloboCare Corp. (the " Company ") entered into securities purchase agreements (the " Purchase Agreements ") with certain institutional investors ("the " Purchasers ") for the issuance and sale in a private placement
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.